News | Radiation Therapy | May 20, 2016

ASTRO Announces Highlights of 2016 Annual Meeting

Keynote speakers to include former HHS Secretary Sebelius, Delta Airlines safety executive and Massachusetts General Hospital physicians group CEO

May 20, 2016 — Registration opened this week for the American Society for Radiation Oncology’s (ASTRO) 58th Annual Meeting, Sept. 25-28 at the Boston Convention and Exhibition Center.

This year’s meeting will feature a record number of abstracts, scientific and educational presentations on radiation oncology clinical trials, and research and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization, and a top safety executive from Delta Air Lines.

The meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

Led by ASTRO President David C. Beyer, M.D., FASTRO, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based healthcare. “The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation,” said Beyer.

Three keynote addresses will examine various aspects of value in healthcare, such as safety, quality and access. Keynote speakers include:

  • Kathleen Sebelius, former U.S. Secretary of Health and Human Services;
  • Thomas James Lynch Jr., M.D., chair and chief executive officer, Massachusetts General Physicians Organization; and
  • Jason Ragogna, general manager, SMS and safety alliances, corporate safety, security and compliance, Delta Air Lines Inc.

The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” will feature Louis Potters, M.D., FASTRO, and Jeff M. Michalski, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the value-based care for prostate cancer.

Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof